PharmaTelevision - Anthony Venturino, Partner at Novak Druce + Quigg, LLP talks about the key issues of patents in the emerging markets and the importance of relationships when protecting IP rights

Anthony Venturino, Partner at Novak Druce + Quigg, LLP talks about the key issues of patents in the emerging markets and the importance of relationships when protecting IP rights

Episode Loading...

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Anthony Venturino, Partner at Novak Druce + Quigg, LLP talks about the key issues of patents in the emerging markets and the importance of relationships when protecting IP rights

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Anthony Venturino, Partner of Novak Druce + Quigg, LLP

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Novak Druce + Quigg LLP: Focus and Practice

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at the LESI Conference in London 2011. On this show I have Anthony P. Venturino, who is a Partner at a company called Novak Druce a Law Firm, welcome to the show.

Anthony P. Venturino:

Thank you.

Fintan Walton:

Tony, you are a patent lawyer could you tell us little bit about what your practice actually is?

Anthony P. Venturino:

It's mostly what they call patent prosecution and procurements or your writing and then after you write the case and file it trying get that thing allowed.

Fintan Walton:

Sure and does that involve patent strategies as well?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Anthony P Venturino

Partner

Anthony P. Venturino currently serves as Partner at Novak Druce + Quigg LLP. Anthony P. Venturino has prepared numerous U.S. and PCT patent applications, trademark applications and opinions, and participated in major litigations. He has also been responsible for a number of complex activities including negotiating and drafting agreements, conducting due diligence for multi-million dollar technology acquisitions, and counseling senior management on intellectual property issues. Anthony P. Venturino has corporate and law firm experience as a chemical engineer with Exxon, is a licensed professional engineer in New Jersey, and was also a patent counsel with U.S. Surgical Corporation. His fields of technical expertise include chemistry, catalysts, oil, gas and coal processing, metallurgy, surfactants, polymers, pharmaceuticals, compositions, biotechnology, and medical devices. He has lectured extensively on U.S. patent practice both in the United States and abroad. He is ranked as "AV" from Martindale Hubbell Law Directory, the highest rating given to participating attorneys. Over the years, Anthony P. Venturino has been recognized by his peers as a top lawyer in his field.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

Novak Druce + Quigg LLP

Novak Druce + Quigg LLP is a national law firm focused exclusively on complex intellectual property matters. With a renowned reexamination practice and over 80 attorneys and professionals in offices in Houston, TX, San Francisco, CA, Washington, DC and West Palm Beach, FL, Novak Druce attorneys help clients navigate the complexities of U.S. intellectual property law by securing, enforcing, and defending their intellectual property rights. The Novak Druce Centre for Professional Service Firms at the University of Oxford's Said Business School launched in October 2009. The Centre explores key challenges confronting the professional services sector, conducts research and provides training to further the advancement of the management of professional service firms.